Key result
Higher soluble thrombomodulin levels linked to ~82% lower risk of first-ever hemorrhagic stroke.
Why the study?
The predictive value of soluble thrombomodulin and von Willebrand factor for first-ever ischemic or hemorrhagic stroke was unclear.
Do soluble thrombomodulin (sTM) and von Willebrand factor (VWF) levels predict a first-ever ischemic or hemorrhagic stroke?
Case-Control (n=324)
Do soluble thrombomodulin (sTM) and von Willebrand factor (VWF) levels predict a first-ever ischemic or hemorrhagic stroke?
Higher levels of soluble thrombomodulin may be associated with a decreased risk of hemorrhagic stroke, though larger studies are needed to confirm this finding.
Answers are grounded in this paper and cite their sources.
sTM may inversely associate with hemorrhagic stroke risk; leaves open predictive value in larger prospective cohorts.
The aim of the present study was to examine if soluble thrombomodulin (sTM) and von Willebrand factor (VWF) could predict a first-ever ischemic or hemorrhagic stroke. This study was an incident case-referent study from within a population-based cohort in northern Sweden. Up to 1996 about 44,000 subjects had been screened and stroke cases were classified according to the WHO MONICA criteria. A first-ever stroke occurred in 108 cases. A total of 216 controls were selected from the same cohort. This prospective study found no association with sTM or VWF and the development of a first-ever ischemic stroke (n = 87) in the logistic regression model. For the hemorrhagic stroke cases (n = 18), the multivariate logistic regression model revealed a significant negative association with sTM. When dichotomized, the upper level (>17.3 microg/L) of sTM, as compared with the lower level (<17.3 microg/L), showed one fifth of the risk for hemorrhagic stroke (OR, 0.18; CI, 0.05 to 0.69). No significant association was found for VWF. We suggest that the novel finding of an inverse relation between sTM and hemorrhagic stroke should be investigated in a larger study.
No takes yet. Share an insight, caveat, or question.
Jansson et al. (2002) conducted a case-control in Ischemic and hemorrhagic stroke (n=324). Soluble thrombomodulin (sTM) and von Willebrand factor (VWF) vs. Lower levels of sTM (<17.3 microg/L) was evaluated on First-ever hemorrhagic stroke (OR 0.18, 95% CI 0.05 to 0.69). Higher levels of soluble thrombomodulin were associated with a reduced risk of first-ever hemorrhagic stroke compared to lower levels.
Synapse has enriched 10 related papers. Consider them for comparative context: